ZP
RAIN

Zimmer Partners’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Zimmer Partners’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,000
Closed -$155K – 203
2021
Q2 		$155K Buy
+10,000
New +$175K ﹤0.01% 172

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Zimmer Partners's RAIN Position: Q3 2021 in Review

Zimmer Partners sold out of Rain Oncology Inc. Common Stock (RAIN) in Q3 2021, closing a stake of 10,000 shares — an estimated $155K sold.

Zimmer Partners first reported a position in RAIN in Q2 2021 and held it in 1 quarter. The position peaked at $155K in Q2 2021. 44 funds tracked by Wall St. Rank hold RAIN as of Q3 2021.

  • Zimmer Partners reported no remaining Rain Oncology Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Zimmer Partners sold 10,000 Rain Oncology Inc. Common Stock shares in Q3 2021, an estimated $155K.
  • Zimmer Partners first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Zimmer Partners's Rain Oncology Inc. Common Stock position peaked at $155K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q3 2021.

Based on Zimmer Partners's 13F filing for Q3 2021, filed 15 Nov 2021.